180 Life Sciences Corp.
ATNF
$1.81
-$0.03-1.63%
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
--
Headlines
3/16/2023
-
Zolmax
2/27/2023
-
Globe Newswire
2/23/2023
-
InvestorPlace
2/23/2023
-
Globe Newswire
2/22/2023
-
Globe Newswire
1/29/2023
-
Ticker Report
1/29/2023
-
Zolmax
1/25/2023
-
Globe Newswire
1/17/2023
-
Globe Newswire
1/10/2023
-
Business Wire
1/5/2023
-
Globe Newswire
1/4/2023
-
Globe Newswire
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
--
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, November 10, 2022
Period Date
Friday, September 30, 2022
Next Filing
Week of Mar 27 and 31 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 507 0669
Address
Building 4
3000 El Camino Real - Suite 200
Palo Alto, CA 94306
3000 El Camino Real - Suite 200
Palo Alto, CA 94306
Country
Year Founded
Business Description
Sector
1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its...
more
